Use of Cadmium [🇷 for BE/BA]

posted by ElMaestro  – Denmark, 2011-01-20 18:53 (5626 d 11:09 ago) – Posting: # 6462
Views: 34,824

OK, here what I meant with my last posts and the gibberish code.

[image]

We have for instance 24 patients in a 2,2,3-BE trial, expected T/R being 1.0 and expected CV is 30%. This gives us a power of 0.87. Scaling preserves power. Thus should the variability be 50% and with preserved power we have 0.6983 as our lower acceptance range and 1.4320 as the upper. Wunderbar. This is the blue line, or shall we call it the EMA line.

I propose to check how the behavior is once the expected R/T diviates from 1.0 and being 0.95 (red), 0.90 (yellow) and 0.85 (green); these curves preserve the power within themselves but of course not between them. It was intended as a graphical illustration of the limitation of the EMA approximation when T/R differs from 1.0.

Note: We are now no longer so intimately connected with the original thread topic.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
140 visitors (0 registered, 140 guests [including 14 identified bots]).
Forum time: 07:03 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5